Pre-existing SARS-2-specific T  cells are predicted to cross-recognize BA.2.86

Cell Host Microbe. 2023 Dec 1:S1931-3128(23)00460-2. doi: 10.1016/j.chom.2023.11.010. Online ahead of print.ABSTRACTEffective monitoring of evolving SARS-CoV-2 variants requires understanding the potential effect of mutations on immune evasion. Here, we predicted the impact of BA.2.86-associated mutations on SARS-CoV-2-specific T cell responses. First, evaluating the effect on known experimentally defined T cell epitopes, we found that 72% and 89% of the total SARS-CoV-2 CD4 and CD8 responses were 100% conserved, with lower rates (56% and 72%) for just spike, a major structural protein. Among the mutated spike epitopes, however, 96% and 62% still bound the same reported HLA-restricting alleles. Additional prediction analyses comparing the ancestral and BA.2 sequences with BA.2.86 mutations identified several potentially novel BA.2.86 epitopes. By simulating exposure with BA.2, the large number of epitopes conserved with BA.2.86 suggests that variant-specific epitopes induced following breakthrough infection or bivalent vaccination can bridge the gap between ancestral immunization and upcoming circulating variants, allowing for a more stable T cell response across viral evolution.PMID:38070502 | DOI:10.1016/j.chom.2023.11.010
Source: Cell Host and Microbe - Category: Microbiology Authors: Source Type: research
More News: Microbiology | SARS | Vaccines